National routine information on drug use and patterns of use amongst prisoners is rare. Most of the data available in the EU come from ad-hoc studies amongst prisoners, carried out at local level, with samples that vary considerably in size and which are often not representative of the whole prison system. This makes extrapolation to a national figure for the prison system very difficult. Furthermore, the lack of repeated surveys impedes trend analysis in most of the EU countries.

There are over 300 statistical tables in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).

The Dataset contains in the amount spent by Government of India towards various efforts to free Indian prisoners from foreign jails. The is country wise information provided in 2018 for the time period March 2015 to March 2018

BackgroundPregabalin is a gamma-aminobutyric acid (GABA) analog that was approved in the EU in 2004 for the treatment of neuropathic pain, generalized anxiety disorder and epilepsy. Since its introduction, pregabalin abuse and misuse has increased significantly. In Switzerland, clinical reports suggest that pregabalin misuse is common among patients in forensic hospitals and prisons. However, data on pregabalin use is scarce, especially in these settings. Therefore, we conducted a study to explore patterns of pregabalin use among prison and forensic patients.MethodsWe used a questionnaire to survey physicians working in prison and forensic medicine in German-speaking countries. A total of 131 responses were received.ResultsAccording to the physicians' subjective assessment, 82.5% of them had observed a recent increase in pregabalin use by their patients and 89.1% of them reported that their patients requested pregabalin without a clear medical indication. Patients misusing pregabalin in combination with other illicit substances were observed by 93.3% of the physicians surveyed. According to 73.5% of the physicians surveyed, they had already encountered patients on pregabalin doses of more than 600 mg/day (the maximum recommended daily dose); the highest dose reported was 4,200 mg/day. According to 85.0% of physicians surveyed, they have observed patients experiencing withdrawal symptoms from pregabalin, with the most commonly reported symptoms being displeasure and high aggression. Regarding the nationality of pregabalin-misusing patients, 58.3% of the interviewed physicians reported to be rather in contact with foreign patients, mainly from Northwest Africa (Maghreb). Only 45.0% of the surveyed physicians prescribe pregabalin. Among patients who developed behavioral problems while taking pregabalin, none of the physicians (0.0%) showed a tendency to continue pregabalin at the same dose; all respondents chose to reduce/substitute/discontinue.ConclusionOur study has provided confirmatory evidence that the use of pregabalin presents a significant issue in forensic and prison medicine across German-speaking countries. Prescribing pregabalin in this field can compound use disorder problems and exacerbate challenges in daily life for those in forensic institutions or prisons. It is necessary that all physicians who prescribe pregabalin are clearly informed about the management (including the risks) of this drug.

Since its development in 1985 by Melvin and colleagues, Attitudes Towards Prisoners scale (ATP) has been employed to measure attitudes towards ex offenders. However, our current knowledge of public attitudes towards ex offenders is limited primarily to a) Anglo-Saxon countries and Hong Kong and b) non-random samples. The present paper differs from most of the previous research in its use of random urban sample in a hitherto unexplored jurisdiction and multivariate analysis to identify demographic correlates of public attitudes towards ex offenders. The representative urban sample in the capital city of Azerbaijan (n=390) points to relatively positive attitudes towards ex-prisoners. Knowledge of a former or current convict and being male are associated with a more positive attitude. Attitudes become more tolerant as age and the level of education increase. The findings show the validity and applicability of ATP in a post-Soviet context, and similar attitudes between Azerbaijani sample and participants elsewhere.